simvastatin (+) ezetimibe

DRUG3 trials

Sponsors

Organon and Co

Conditions

Hypercholesterolemia

Phase 3

A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)

CompletedNCT00496730

Organon and CoHypercholesterolemia

Start: 2007-07-31End: 2008-08-31Updated: 2024-05-16

Phase 4

Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)

CompletedNCT00157924

Organon and CoHypercholesterolemia

Start: 2005-11-30End: 2007-09-30Updated: 2024-06-07

Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

CompletedNCT00442897

Organon and CoHypercholesterolemia

Start: 2006-09-30End: 2008-10-31Updated: 2024-05-22